Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department

Pediatric Emergency Care

Volumn 30, Issue 6, 2014, Pages 388-393

  Díaz Parra, Sandra ^a   Sánchez Yañez, Pilar ^a   Zabala Argüelles, Ignacio ^a   Picazo Angelin, Beatriz ^a   Conejo Muñoz, Lourdes ^a   Cuenca Peiró, Victorio ^a   Durán Hidalgo, Isabel ^a   García Soler, Patricia ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

adenosine; doses; supraventricular tachycardia

Indexed keywords

ADENOSINE; AMIODARONE; ESMOLOL; ANTIARRHYTHMIC AGENT;

ARTICLE; CARDIOVERSION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONSULTATION; DYSPNEA; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART PALPITATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LOADING DRUG DOSE; MALE; PATIENT MONITORING; PATIENT TRANSPORT; PEDIATRIC WARD; PEDIATRICS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TERTIARY CARE CENTER; THORAX PAIN; TREATMENT RESPONSE; ADOLESCENT; DOSE RESPONSE; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; INFANT; RISK FACTOR; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

ADENOSINE; ADOLESCENT; ANTI-ARRHYTHMIA AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84902544640     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0000000000000144     Document Type: Article

References (21)

1. Almendral J, Castellanos E, Ortiz M. Paroxysmal supraventricular tachycardia and preexcitation syndrome. Rev Esp Cardiol. 2012;65: 456-469.
2. Ko JK, Deal BJ, Strasburger JF, et al. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69:1028-1032.
3. Rodriguez LM, de Chillou C, Metzger J. Age at onset and gender of patients with different types of supraventricular tachycardias. J Am Coll Cardiol. 1992;70:1213-1215.
4. Kinoshita O, Agatsuma T, Hanaoka T, et al. Surgical treatment of patients with Wolff-Parkinson-White syndrome and associated Ebstein's anomaly. J Thorac Cardiovasc Surg. 1995;110:1702-1707.
5. Khositseth A, Danielson GK, Dearani JA, et al. Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg. 2004;128:826-833.
6. Garson A, Gillette PC, Mc Namara D. Supraventricular tachycardia in children: clinical features, response to treatment and long term follow up in 217 patients. J Pediatr. 1981;98:875-882.
7. Ros SP, Fisher EA, Bell TJ. Adenosine in the emergency management of supraventricular tachycardia. Pediatr Emerg Care. 1991;7:222-223.
8. Reyes G, Stanton R, Galvis AG. Adenosine in the treatment of paroxysmal supraventricular tachycardia in children. Ann Emerg Med. 1992;21:1499-1501.
9. Camm AC, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med. 1991;325:1621-1629.
10. Salerno JC, Seslar SP Supraventricular tachycardia. Arch Pediatr Adolesc Med. 2009;163:268-274.
11. Mioara D, Manole MD, Richard A, et al. Emergency department management of the pediatric. Patient with supraventricular tachycardia. Pediatr Emerg Care. 2007;23:176-189.
12. Perry JC, Garson A Jr. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol. 1990;16:1215-1220.
13. Balaguer Gargallo M, Jordan Garćia I, Caritg Bosch J, et al. Taquicardia parox́istica supraventricular en el nino y el lactante. An Pediatr. 2007;67: 133-138.
14. Blomstrom-Lundqvist, Scheinman. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology. Committee for Practice Guidelines. Eur Heart J. 2003;24:1857-1897.
15. Losek JD, Endom E, Dietrich A, et al. Adenosine and pediatric supraventricular tachycardia in the emergency department: multicenter study and review. Ann Emerg Med. 1999;33:185-191.
16. Till J, Shinebourne EA, Rigby ML, et al. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J. 1989;62:204-211.
17. Paul T, Pfammatter JP Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol. 1997;18:118-126.
18. Kleinman ME, Chameides L, Schexnayder SM, et al. Pediatric advanced life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics. 2010;126:e1361-e1399.
19. Dixon J, Foster K, Wyllie J, et al. Guidelines and adenosine dosing in supraventricular tachycardia. Arch Dis Child. 2005;90:1190-1191.
20. Sherwood MC, Lau KC, Sholler GF Adenosine in the management of supraventricular tachycardia in children. JPaediatr Child Health. 1998;34:53-56.
21. Qureshi AU, Hyder SN, Sheikh AM, et al. Optimal dose of adenosine effective for supraventricular tachycardia in children. J Coll Physicians Surg Pak. 2012;22:648-651.